{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:04:10Z","timestamp":1792184650885,"version":"4.4.0"},"reference-count":18,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Neuropsychopharm Rep"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The development of clinical practice guidelines for social anxiety disorder began in March 2018 when the Joint Clinical Practice Guideline Development Committee for Anxiety and Obsessive\u2013Compulsive Disorders was formed by the Japanese Society of Anxiety and Related Disorders and Japanese Society of Neuropsychopharmacology to jointly develop guidelines for anxiety and obsessive\u2013compulsive disorders. Based on the universal concept of evidence\u2010based medicine, three clinical questions (CQs) about pharmacotherapy and psychotherapy were developed for clinical guidelines for social anxiety disorder, panic disorders, and obsessive\u2013compulsive disorder in accordance with the Minds Manual for Guidelines Development 2017 by the Japan Council for Quality Health Care: CQ1\u2014\u201cWhat is the recommended pharmacotherapy for social anxiety disorder in adults?\u201d; CQ2\u2014\u201cWhat is the recommended psychotherapy (psychological intervention) for social anxiety disorder in adults?\u201d; and CQ3\u2014\u201cWhat are the recommendations regarding monotherapy and combination therapy for social anxiety disorder in adults in terms of pharmacotherapy and psychotherapy (psychological interventions)?\u201d Summarized recommendations for social anxiety disorder in adults are selective serotonin reuptake inhibitors and serotonin\u2010norepinephrine reuptake inhibitor for CQ1, cognitive behavioral therapy for CQ2, and there are no recommendations regarding monotherapy and combination therapy for CQ3. These were answered by considering the balance between benefits and harms based on systematic reviews of each. The aim of this brief guideline for the standard\u2010of\u2010care (i.e., medical treatment) for social anxiety disorder in adults (18\u2009years and older) was to help \u201cshared decision making,\u201d in which medical professionals, including physicians, and patients share scientific evidence to decide on a course of treatment.<\/jats:p>","DOI":"10.1002\/npr2.12365","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T18:50:03Z","timestamp":1692989403000},"page":"288-309","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Japanese Society of Anxiety and Related Disorders\/Japanese Society of Neuropsychopharmacology: Clinical practice guideline for social anxiety disorder (2021)"],"prefix":"10.1002","volume":"43","author":[{"given":"Satoshi","family":"Asakura","sequence":"first","affiliation":[{"name":"Japanese Society of Anxiety and Related Disorders  Tokyo Japan"},{"name":"Japanese Society of Neuropsychopharmacology  Tokyo Japan"},{"name":"Department of Psychiatry, Hokkaido University Graduate School of Medicine\/Health Care Center Hokkaido University  Sapporo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4438-9746","authenticated-orcid":false,"given":"Naoki","family":"Yoshinaga","sequence":"additional","affiliation":[{"name":"Japanese Society of Anxiety and Related Disorders  Tokyo Japan"},{"name":"School of Nursing, Faculty of Medicine University of Miyazaki  Miyazaki Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0933-2330","authenticated-orcid":false,"given":"Hisashi","family":"Yamada","sequence":"additional","affiliation":[{"name":"Japanese Society of Anxiety and Related Disorders  Tokyo Japan"},{"name":"Japanese Society of Neuropsychopharmacology  Tokyo Japan"},{"name":"Department of Neuropsychiatry Hyogo College of Medicine  Nishinomiya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3928-7630","authenticated-orcid":false,"given":"Yutaka","family":"Fujii","sequence":"additional","affiliation":[{"name":"Japanese Society of Anxiety and Related Disorders  Tokyo Japan"},{"name":"Japanese Society of Neuropsychopharmacology  Tokyo Japan"},{"name":"Department of Psychiatry, Hokkaido University Graduate School of Medicine\/Health Care Center Hokkaido University  Sapporo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0788-7690","authenticated-orcid":false,"given":"Nobuyuki","family":"Mitsui","sequence":"additional","affiliation":[{"name":"Japanese Society of Anxiety and Related Disorders  Tokyo Japan"},{"name":"Japanese Society of Neuropsychopharmacology  Tokyo Japan"},{"name":"Department of Psychiatry, Hokkaido University Graduate School of Medicine\/Health Care Center Hokkaido University  Sapporo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1299-4068","authenticated-orcid":false,"given":"Yoshihiro","family":"Kanai","sequence":"additional","affiliation":[{"name":"Japanese Society of Anxiety and Related Disorders  Tokyo Japan"},{"name":"Department of Psychology and Behavioral Sciences, Faculty of Human Sciences Tohoku Gakuin University  Sendai Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5248-1289","authenticated-orcid":false,"given":"Takeshi","family":"Inoue","sequence":"additional","affiliation":[{"name":"Japanese Society of Anxiety and Related Disorders  Tokyo Japan"},{"name":"Japanese Society of Neuropsychopharmacology  Tokyo Japan"},{"name":"Department of Psychiatry Tokyo Medical University  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6741-9338","authenticated-orcid":false,"given":"Eiji","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Japanese Society of Anxiety and Related Disorders  Tokyo Japan"},{"name":"Japanese Society of Neuropsychopharmacology  Tokyo Japan"},{"name":"Department of Cognitive Behavioral Physiology, Graduate School of Medicine Chiba University  Chiba Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,8,25]]},"reference":[{"issue":"10","key":"e_1_2_8_3_2_1","first-page":"Cd001206","article-title":"Pharmacotherapy for social anxiety disorder (SAnD)","volume":"10","author":"Williams T","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_3_3_1","volume-title":"Social Anxiety Disorder: Recognition, Assessment and Treatment (Clinical Guideline [CG159])","author":"National Institute for Health and Care Excellence (NICE)","year":"2013"},{"issue":"27","key":"e_1_2_8_3_4_1","first-page":"473","article-title":"The diagnosis of and treatment recommendations for anxiety disorders","volume":"111","author":"Bandelow B","year":"2014","journal-title":"Dtsch Arztebl Int"},{"key":"e_1_2_8_3_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-14-S1-S1"},{"key":"e_1_2_9_1_11_2_1","volume-title":"Social Anxiety Disorder: Recognition, Assessment and Treatment (Clinical Guideline [CG159])","author":"National Institute for Health and Care Excellence (NICE)","year":"2013"},{"key":"e_1_2_9_1_11_3_1","volume-title":"NICE guideline CG159","author":"National Institute for Health and Care Excellence (NICE). Surveillance report 2017 \u2013 Social Anxiety Disorder: Recognition, Assessment and Treatment","year":"2013"},{"key":"e_1_2_9_1_11_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(14)70329-3"},{"key":"e_1_2_9_1_11_5_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1754470X20000574"},{"key":"e_1_2_9_1_11_6_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1754470X18000211"},{"key":"e_1_2_9_1_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2005.10.001"},{"key":"e_1_2_9_1_11_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-7894(05)80062-0"},{"key":"e_1_2_9_1_11_9_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.12r07757"},{"key":"e_1_2_9_1_11_10_1","doi-asserted-by":"publisher","DOI":"10.1159\/000235981"},{"key":"e_1_2_9_1_11_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-9-37"},{"key":"e_1_2_9_1_11_12_1","doi-asserted-by":"publisher","DOI":"10.1159\/000500108"},{"key":"e_1_2_9_3_2_1","volume-title":"Social Anxiety Disorder: Recognition, Assessment and Treatment (Clinical Guideline [CG159])","author":"National Institute for Health and Care Excellence (NICE)","year":"2013"},{"key":"e_1_2_9_3_3_1","volume-title":"NICE Guideline CG159","author":"National Institute for Health and Care Excellence (NICE). Surveillance report 2017 \u2013 Social Anxiety Disorder: Recognition, Assessment and Treatment (2013)","year":"2017"},{"key":"e_1_2_16_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2016.1146663"}],"container-title":["Neuropsychopharmacology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/npr2.12365","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T15:56:35Z","timestamp":1726070195000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/npr2.12365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,25]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1002\/npr2.12365"],"URL":"https:\/\/doi.org\/10.1002\/npr2.12365","archive":["Portico"],"relation":{},"ISSN":["2574-173X","2574-173X"],"issn-type":[{"value":"2574-173X","type":"print"},{"value":"2574-173X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,25]]},"assertion":[{"value":"2023-05-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}